Your browser doesn't support javascript.
loading
Substance P Antagonist Aprepitant Shows no Additive Effect Compared with Standardized Topical Treatment Alone in Patients with Atopic Dermatitis.
Lönndahl, Louise; Holst, Mikael; Bradley, Maria; Killasli, Hassan; Heilborn, Johan; Hall, Martin A; Theodorsson, Elvar; Holmberg, Jadwiga; Nordlind, Klas.
Affiliation
  • Lönndahl L; Dermatology and Venereology Unit, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, SE-17176 Stockholm, Sweden. louise.lonndahl@ki.se.
Acta Derm Venereol ; 98(3): 324-328, 2018 Mar 13.
Article in En | MEDLINE | ID: mdl-29182791
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pruritus / Skin / Substance P / Morpholines / Dermatitis, Atopic / Neurokinin-1 Receptor Antagonists / Antipruritics Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Acta Derm Venereol Year: 2018 Document type: Article Affiliation country: Sweden Country of publication: Sweden
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pruritus / Skin / Substance P / Morpholines / Dermatitis, Atopic / Neurokinin-1 Receptor Antagonists / Antipruritics Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Acta Derm Venereol Year: 2018 Document type: Article Affiliation country: Sweden Country of publication: Sweden